Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Chymase 1, Mast Cell (CMA1) Peptide

CMA1 Reactivity: Mammalian Host: Synthetic BP, WB, IHC
Catalog No. ABIN938181

Quick Overview for Chymase 1, Mast Cell (CMA1) Peptide (ABIN938181)

Target

CMA1 (Chymase 1, Mast Cell (CMA1))

Origin

Mammalian

Source

  • 3
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Peptide Type

    Synthetic

    Sequence

    EVKLRLMDPQ ACSHFRDFDH NLQLCVGNPR KTKSAFKGDS GGPLLCAGVA

    Characteristics

    A synthetic peptide for use as a blocking control in assays to test for specificity of CMA1 antibody,
    Alternative Names: CMA1 control peptide, CMA1 antibody Blocking Peptide, Anti-CMA1 Blocking Peptide, chymase 1, mast cell Blocking Peptide, CYH Blocking Peptide, MCT1 Blocking Peptide, MGC119890 Blocking Peptide, MGC119891 Blocking Peptide, chymase Blocking Peptide, CMA1, CMA-1, CMA 1, CMA-1 Blocking Peptide, CMA 1 Blocking Peptide
  • Application Notes

    Optimal conditions should be determined by the investigator

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.

    Buffer

    PBS

    Handling Advice

    Avoid repeated freeze/thaw cycles.

    Storage

    -20 °C

    Storage Comment

    Store at -20 °C long term.
  • Target

    CMA1 (Chymase 1, Mast Cell (CMA1))

    Background

    CMA1 is a chymotryptic serine proteinase that belongs to the peptidase family S1. It is expressed in mast cells and thought to function in the degradation of the extracellular matrix, the regulation of submucosal gland secretion, and the generation of vasoactive peptides. In the heart and blood vessels, this protein, rather than angiotensin converting enzyme, is largely responsible for converting angiotensin I to the vasoactive peptide angiotensin II. Angiotensin II has been implicated in blood pressure control and in the pathogenesis of hypertension, cardiac hypertrophy, and heart failure. Thus, this gene product is a target for cardiovascular disease therapies.

    Molecular Weight

    27 kDa
You are here:
Chat with us!